Loop Capital set a $115.00 price target on Core Laboratories (NYSE:CLB) in a report published on Thursday. The firm currently has a buy rating on the oil and gas company’s stock.

Several other equities analysts have also issued reports on the stock. Credit Suisse Group upgraded shares of Core Laboratories from a neutral rating to an outperform rating and set a $110.00 target price on the stock in a report on Thursday, August 24th. They noted that the move was a valuation call. Royal Bank Of Canada dropped their target price on shares of Core Laboratories from $115.00 to $112.00 and set an outperform rating on the stock in a report on Thursday, September 7th. ValuEngine lowered shares of Core Laboratories from a hold rating to a sell rating in a report on Friday, September 1st. Zacks Investment Research upgraded shares of Core Laboratories from a sell rating to a hold rating in a report on Tuesday, September 12th. Finally, Cowen restated a hold rating and issued a $100.00 target price on shares of Core Laboratories in a report on Friday, September 1st. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the stock. The stock has a consensus rating of Hold and an average target price of $110.40.

Core Laboratories (CLB) opened at $101.00 on Thursday. The stock has a market cap of $4,458.88, a price-to-earnings ratio of 55.19 and a beta of 1.56. The company has a quick ratio of 1.81, a current ratio of 2.18 and a debt-to-equity ratio of 1.53. Core Laboratories has a fifty-two week low of $86.55 and a fifty-two week high of $125.83.

Core Laboratories (NYSE:CLB) last released its earnings results on Monday, October 23rd. The oil and gas company reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.04. The business had revenue of $166.20 million for the quarter, compared to analyst estimates of $160.94 million. Core Laboratories had a net margin of 12.06% and a return on equity of 52.89%. Core Laboratories’s revenue for the quarter was up 1.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.38 earnings per share. equities analysts expect that Core Laboratories will post 1.99 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 21st. Shareholders of record on Friday, October 20th were paid a $0.55 dividend. This represents a $2.20 annualized dividend and a yield of 2.18%. The ex-dividend date of this dividend was Thursday, October 19th. Core Laboratories’s dividend payout ratio (DPR) is currently 126.44%.

Institutional investors and hedge funds have recently bought and sold shares of the business. Parallel Advisors LLC increased its stake in Core Laboratories by 13.1% in the second quarter. Parallel Advisors LLC now owns 1,008 shares of the oil and gas company’s stock valued at $101,000 after purchasing an additional 117 shares in the last quarter. The Manufacturers Life Insurance Company increased its stake in Core Laboratories by 63.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock valued at $114,000 after purchasing an additional 439 shares in the last quarter. Advisory Services Network LLC increased its stake in Core Laboratories by 33.3% in the second quarter. Advisory Services Network LLC now owns 1,365 shares of the oil and gas company’s stock valued at $138,000 after purchasing an additional 341 shares in the last quarter. Toronto Dominion Bank increased its stake in Core Laboratories by 243.6% in the third quarter. Toronto Dominion Bank now owns 1,866 shares of the oil and gas company’s stock valued at $184,000 after purchasing an additional 1,323 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership bought a new stake in Core Laboratories in the second quarter valued at $203,000.

COPYRIGHT VIOLATION NOTICE: “Core Laboratories (CLB) Given a $115.00 Price Target by Loop Capital Analysts” was published by Watch List News and is the property of of Watch List News. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.watchlistnews.com/core-laboratories-clb-given-a-115-00-price-target-by-loop-capital-analysts/1756909.html.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.